Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient‐derived xenografts

HemaSphere (Jan 2024)

Affiliations

Vilma Dembitz: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK
Jozef Durko: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK
Joana Campos: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK
Sophie C. James: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK
Hannah Lawson: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK
Kamil R. Kranc: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK
Paolo Gallipoli: Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Abstract

No abstracts available.

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.hemaspherejournal.com